Fig. 2. Hemoglobin levels among patients receiving ferric carboxymaltose vs. no-ferric carboxymaltose at POD 5 and POD 21.

Surg Metab Nutr 2020;11:61-5 https://doi.org/10.18858/smn.2020.11.2.61

© 2020 Surg Metab Nutr